Guided imagery for women having chemotherapy for gynecologic cancer
The Effect of Guided Imagery on Nausea, Vomiting, Anxiety and Quality of Life in Gynecologic Cancer Patients Undergoing Chemotherapy: A Randomized Controlled Trial
NA · Baskent University · NCT07408349
This trial will test whether guided imagery can help women receiving chemotherapy for gynecologic cancers feel physically and emotionally better during treatment.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 46 (estimated) |
| Ages | 18 Years to 90 Years |
| Sex | Female |
| Sponsor | Baskent University (other) |
| Drugs / interventions | chemotherapy |
| Locations | 2 sites (Ankara and 1 other locations) |
| Trial ID | NCT07408349 on ClinicalTrials.gov |
What this trial studies
This is a randomized, controlled trial at Başkent University Ankara outpatient chemotherapy unit that assigns women 1:1 to either a guided imagery intervention or a control group receiving standard information. Participants complete outcome assessments at three time points to compare psychological and physical symptoms across groups. The target sample is 158 women based on a repeated-measures power calculation, and randomization is done via an online tool. The protocol follows CONSORT-Outcomes guidance for reporting.
Who should consider this trial
Good fit: Women with gynecologic cancer who are receiving chemotherapy at Başkent University and are willing to be randomized and to practice guided imagery would be appropriate candidates.
Not a fit: Patients who are not receiving chemotherapy, are unable or unwilling to practice guided imagery, or are too medically unstable to participate are unlikely to benefit from this intervention.
Why it matters
Potential benefit: If successful, guided imagery could reduce chemotherapy side effects and improve psychological well-being and overall quality of life during treatment.
How similar studies have performed: Previous studies, particularly in breast and some gynecologic cancer populations, have reported benefits of guided imagery for symptom management, though research specifically during chemotherapy for gynecologic cancers is limited.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Having a diagnosis of another type of cancer * An ECOG (Eastern Cooperative Oncology Group) performance score of ≥3 (PS 3: Confined to bed for more than half of the day, limited self-care; PS 4: Completely bedridden, unable to perform self-care) Exclusion Criteria: * Choosing to withdraw from the study * Refusing to practice guided imagery before chemotherapy treatment
Where this trial is running
Ankara and 1 other locations
- Başkent University — Ankara, Turkey (Türkiye) (RECRUITING)
- Başkent University — Ankara, Turkey (Türkiye) (RECRUITING)
Study contacts
- Study coordinator: Hatice Kübra YURDAKUL, Msc
- Email: kubraoz86@hotmail.com
- Phone: 0312 246 66 66
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Gynecologic Cancer